There was a collective sigh of relief when it was announced that there was a breakthrough in coming up with the Covid -19 vaccine. This meant that a lot of people would be protected against the severity of the Covid -19 virus if they got it. The highest concern was adults who it was recommended should be the first to partake in the different Covid -19 vaccines made available. The healthcare experts in the health industry and who formed the first line of defense against the Covid-19 virus were also considered as the first group to be vaccinated.
The Covid 19 vaccine however was discouraged from being given to children first who were under the age of eighteen and later it was reduced to children under the age of twelve. The main reason against this was that there lacked enough clinical trials conducted to people under the age of 12 for the Covid -19. It was said that the children would suffer from side effects. It was noted that that the side effects that were suffered by children over twelve who took the Covid vaccine exhibited inflammation of the heart muscle, inflammation of the outside lining of the heart, chest pains. These symptoms are thought to get severe if a younger child was to get the vaccine and therefore discouraged from being administered to younger children.
Younger children who are less than twelve are encouraged to get tested instead and placed on other types of medication available. Covid-19 testing in children can be done through the taking of tissue samples and this is mostly done in hospitals by qualified healthcare. Some companies like Docsun have come up with a non-surgical way of testing for the presence of Covid-19 symptoms. Such devices include the Docsun doorway terminal that uses the oct technology to monitor Covid -19 like symptoms in high traffic areas. There is also the Docsun mobile app that is most suitable for individuals with access to smartphones. They download the app and carry out the test. This testing method is proving a favorite among people since it is as painless as it does not require the giving of any genetic tissue samples.
There have been some vaccines that have been given clearance by different healthcare bodies to be administered to children. The Pfizer vaccine has been cleared for emergency use in children who are under twelve years old. The Comirnaty vaccine was approved to be used by children who are sixteen years and older. According to healthcare experts’ vaccines for younger children, those who are five years and above may be authorized soon as clinical trials are underway.
